APPLICATION
NDA011600
TYPE
NDA
ORIGINAL APPROVAL
1963-07-30
LATEST ACTION
1996-03-18
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued
Products
TRIAMCINOLONE ACETONIDE · ReferenceDiscontinued
TRIAMCINOLONE ACETONIDE 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · OINTMENT · TOPICAL
TRIAMCINOLONE ACETONIDE · ReferenceDiscontinued
TRIAMCINOLONE ACETONIDE 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · OINTMENT · TOPICAL
Approval history
1996-03-18Manufacturing (CMC) · Supplement 30 · standardAP
1993-07-09Manufacturing (CMC) · Supplement 29 · standardAP
1984-08-09Manufacturing (CMC) · Supplement 25 · standardAP
1984-08-08Manufacturing (CMC) · Supplement 24 · standardAP
1983-08-10Manufacturing (CMC) · Supplement 23 · standardAP
1982-12-13Labeling · Supplement 21AP
1981-02-26Manufacturing (CMC) · Supplement 22 · standardAP
1980-01-23Manufacturing (CMC) · Supplement 19 · standardAP
1978-07-05Labeling · Supplement 20AP
1977-10-11Manufacturing (CMC) · Supplement 17 · standardAP
1977-10-11Manufacturing (CMC) · Supplement 18 · standardAP
1977-06-17Labeling · Supplement 16AP
1977-02-04Manufacturing (CMC) · Supplement 15 · standardAP
1976-07-15Manufacturing (CMC) · Supplement 14 · standardAP
1975-06-11Labeling · Supplement 12AP
1974-07-08Supplement · Supplement 10 · standardAP
1963-07-30Type 3 - New Dosage Form · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.